Publications by authors named "Brian Haymart"

Claim this Profile
O
Outcomes of Oral Anticoagulation with Concomitant NSAID Use: A Registry Based Cohort Study.
Nelish Ardeshna, Josh Errickson, Xiaowen Kong, Mona A Ali, Naina Chipalkatti, Brian Haymart

Am J Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Intervention to Reduce Antiplatelet Use without Gastroprotection in Patients Using Warfarin: The AEGIS Cluster Randomized Trial.
Jacob E Kurlander, Danielle Helminski, Xueting Tao, Sameer D Saini, Sarah L Krein, Brian Haymart

Thromb Haemost· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparison of Outcomes With Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous Thromboembolism.
Jordan K Schaefer, Josh Errickson, Xiaowen Kong, Mona A Ali, Naina Chipalkatti, Brian Haymart

JACC Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of Off-Label Dosing of Direct Oral Anticoagulants in Three Large Health Systems.
Grace C Herron, Deborah DeCamillo, Xiaowen Kong, Brian Haymart, Scott Kaatz

Thromb Haemost· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of quality measures before and after switching care models in MAQI2 anticoagulation clinics.
Suzanne Irani, Xiaokui Gu, Brian Haymart, Constantina Alexandris-Souphis, Helen Gikas

Thromb Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of discussions around left atrial appendage occlusion as a treatment option in patients on oral anticoagulation experiencing a major bleeding event.
Amber Co, Chloe Kazaglis, Deborah DeCamillo, Brian Haymart, Brindha Rajakumar

Thromb Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of atrial fibrillation and venous thromboembolism with factor Xa inhibitors in severely obese patients.
Paul Dobry, Stephanie B Edwin, Brian Haymart, Geoffrey D Barnes, Scott Kaatz

J Thromb Haemost· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing rates of clinically relevant epistaxis in patients taking warfarin versus direct oral anticoagulants.
Khristian S Burke, Xiaowen Kong, Brian Haymart, Debbie DeCamillo, Mona Ali

Res Pract Thromb Haemost· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing DOAC and warfarin outcomes in an obese population using the 'real-world' Michigan Anticoagulation Quality Improvement Initiative (MAQI) registry.
Nelish Ardeshna, Thane Feldeisen, Xiaowen Kong, Brian Haymart, Scott Kaatz

Vasc Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Guideline-Discordant Aspirin Use and Associated Adverse Events in Patients on Warfarin for Mechanical Valve Replacement.
Brian Haymart, Xiaowen Kong, Mona Ali, Jordan K Schaefer, James B Froehlich

Am J Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of direct oral anticoagulants with aspirin vs warfarin with aspirin: a registry-based cohort study.
Jordan K Schaefer, Josh Errickson, Xiaowen Kong, Mona A Ali, Deborah DeCamillo, Brian Haymart

Res Pract Thromb Haemost· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexplained hematuria in direct oral anticoagulant use: a single-center retrospective case series.
Deborah DeCamillo, Lindsey A Herrel, Brian Haymart, Ahmaad Latfolla, Geoffrey D Barnes

Res Pract Thromb Haemost· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticoagulation Changes Following Major and Clinically Relevant Nonmajor Bleeding Events in Non-valvular Atrial Fibrillation Patients.
Thane Feldeisen, Constantina Alexandris-Souphis, Brian Haymart, Xiaowen Kong, Eva Kline-Rogers

J Pharm Pract· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events in low versus normal body weight patients prescribed apixaban for atrial fibrillation.
Deborah DeCamillo, Brian Haymart, Xiaowen Kong, Scott Kaatz, Mona A Ali

J Thromb Thrombolysis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher OAK (Oral Anticoagulation Knowledge) score at baseline associated with better TTR (Time in Therapeutic Range) in patients taking warfarin.
Delaney Feldeisen, Constantina Alexandris-Souphis, Brian Haymart, Xiaokui Gu, Linda Perry

J Thromb Thrombolysis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in patients undergoing periprocedural interruption of warfarin or direct oral anticoagulants.
Jeffrey Lee, Xiaowen Kong, Brian Haymart, Eva Kline-Rogers, Scott Kaatz

J Thromb Haemost· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Length of Anticoagulation in Provoked Venous Thromboembolism: A Multicenter Study of How Real-World Practice Mirrors Guideline Recommendations.
Elizabeth Joyce, Brian Haymart, Xiaowen Kong, Mona A Ali, Mara Carrigan

J Am Heart Assoc· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of an Intervention to Reduce Aspirin Prescribing for Patients Receiving Warfarin for Anticoagulation.
Jordan K Schaefer, Josh Errickson, Xiaokui Gu, Tina Alexandris-Souphis, Mona A Ali, Brian Haymart

JAMA Netw Open· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of adding antiplatelet therapy to warfarin for management of venous thromboembolism with bleeding and other adverse events.
Melinda Song, Brian Haymart, Xiaowen Kong, Mona Ali, Scott Kaatz

Vasc Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Patient Outcomes Before and After Switching From Warfarin to a Direct Oral Anticoagulant Based on Time in Therapeutic Range Guideline Recommendations.
Brian Haymart, Geoffrey D Barnes, Xiaowen Kong, Mona Ali, Eva Kline-Rogers

JAMA Netw Open· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management strategies following slightly out-of-range INRs: watchful waiting vs dose changes.
Hallie B Remer, Xiaokui Gu, Brian Haymart, Geoffrey D Barnes, Mona A Ali

Blood Adv· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events in patients taking apixaban or rivaroxaban who have undergone bariatric surgery: a retrospective case series.
Deborah DeCamillo, Brian Haymart, Geoffrey D Barnes

J Thromb Thrombolysis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard Versus Higher Intensity Anticoagulation for Patients With Mechanical Aortic Valve Replacement and Additional Risk Factors for Thromboembolism.
Sarah Hanigan, Xiaowen Kong, Brian Haymart, Eva Kline-Rogers, Scott Kaatz

Am J Cardiol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of temporary interruption with continuation of direct oral anticoagulants for low bleeding risk procedures.
Muhammad Adil Sheikh, Xiaowen Kong, Brian Haymart, Scott Kaatz, Gregory Krol

Thromb Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Events Associated With the Addition of Aspirin to Direct Oral Anticoagulant Therapy Without a Clear Indication.
Jordan K Schaefer, Josh Errickson, Yun Li, Xiaowen Kong, Tina Alexandris-Souphis, Brian Haymart

JAMA Intern Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis